Board Member
2024-03-20–present
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Brian Hansen is recorded as COO at Exelon Corp (EXC) and Board Member at Senseonics Holdings, Inc. (SENS). Brian Hansen was last confirmed as Board Member at Tandem Diabetes Care Inc (TNDM) in a filing dated April 9, 2024. Senseonics Holdings, Inc. reported in an 8-K filed March 25, 2024 that Brian Hansen was appointed director, effective March 20, 2024. Tandem Diabetes Care Inc reported in an 8-K filed August 18, 2023 that Brian Hansen resigned as Executive Vice President and Chief Commercial Officer, effective December 31, 2023. The proxy statement of Tandem Diabetes Care Inc reports total compensation of $1,742,836 for Brian Hansen in fiscal 2022, including a base salary of $437,091. Disclosed compensation is on record for 6 fiscal years. Brian Hansen has spoken on 2 earnings calls across 1 company, most recently for Senseonics Holdings, Inc. on May 7, 2026.
“On March 20, 2024, the Board appointed Brian Hansen to serve as a director of the Company.”
“On August 17, 2023, Brian B. Hansen, Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the Company), notified the Company of his decision to resign from his role as Executive Vice President and Chief Commercial Officer, effective December 31, 2023 (the Effective Date).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-03-20–present
Proxy statement
Start not stated–present
Start not stated–2024-04-09
Last confirmed by a filing; no departure on record
Proxy statement
Start not stated–2023-12-31
Recorded roles and call appearances connecting this person to public companies.
Board Member
2024-03-20–present
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Tandem Diabetes Care Inc (TNDM) | Former Executive Vice President, Chief Commercial Officer | $437,091 | $1,742,836 |
| 2021 | Tandem Diabetes Care Inc (TNDM) | Former Executive Vice President, Chief Commercial Officer | $424,360 | $1,629,866 |
| 2020 | Tandem Diabetes Care Inc (TNDM) | Executive Vice President, Chief Commercial Officer | $412,000 | $1,957,086 |
| 2019 | Tandem Diabetes Care Inc (TNDM) | Executive Vice President, Chief Commercial Officer | $400,000 | $5,399,897 |
| 2018 | Tandem Diabetes Care Inc (TNDM) | Executive Vice President, Chief Commercial Officer | $386,250 | $1,935,611 |
| 2017 | Tandem Diabetes Care Inc (TNDM) | Executive Vice President, Chief Commercial Officer | $375,000 | $607,851 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.